Study wrapper · #196
Analysis of new growth promoting black market products.
Editor's note
An analytical-chemistry study from a sports anti-doping lab, not an efficacy study. Using high-resolution mass spectrometry, researchers characterised black-market growth-promoting products and identified a modified growth hormone (an extra N-terminal alanine, 192 versus 191 residues) plus three glycine-extended GHRP analogues, Gly-GHRP-6, Gly-GHRP-2 and Gly-Ipamorelin, with two confirmed by custom synthesis. This matters to AllAboutAminos readers for a reason other than efficacy: it is direct evidence that products sold in this market can contain altered or non-standard molecules, not the labelled compound. Neither GHRP-6 nor ipamorelin was tested for any health effect here; the study measured structures, not outcomes, and included only preliminary in-vitro metabolism work. For anyone tracking these growth-hormone secretagogues, the takeaway is a quality-and-identity caution, that what is in the vial may not be what the label claims, rather than anything about benefit or safety of the peptides themselves.
Plain-language abstract
This is a laboratory chemistry study aimed at drug testing, not a test of whether these peptides work. Anti-doping scientists analysed growth-promoting products from the black market to work out exactly what molecules they contained. Using precise mass-measuring instruments, they found a slightly altered form of human growth hormone carrying one extra building block (an added alanine), making it 192 amino acids instead of the usual 191. They also identified three altered versions of growth-hormone-releasing peptides, labelled Gly-GHRP-6, Gly-GHRP-2, and Gly-Ipamorelin, each carrying an extra glycine unit at one end. For two of these, they confirmed the structure by making the molecule from scratch and comparing it. Early cell-based experiments gave preliminary clues about how the body might break these down. The main lesson is that products in this market may contain modified or unexpected substances; the study did not measure any benefit, side effect, or safety outcome in people.